
Explore cutting-edge nanophotonics-driven digital resolution biomolecule sensing combined with target molecule recycling for ultrasensitive and ultraselective liquid biopsy techniques.

Expertos de Stanford discuten cambios demográficos, factores de riesgo, síntomas y avances en diagnóstico y tratamiento del cáncer de pulmón, incluyendo cirugía, radioterapia e inmunoterapia.

Explore targeted sequencing concordance between ctDNA and tumor samples in early breast cancers. Gain insights into non-invasive testing potential and implications for liquid biopsy in clinical practice.

Explore non-invasive cancer monitoring through liquid biopsy, focusing on Blocker Displacement Amplification technology for improved detection and longitudinal tracking of cancer biomarkers.

Explore liquid biopsy applications in head and neck cancer, covering diagnosis through survivorship with Dr. Holsinger's expert insights.

Explore proteomics-based models for non-invasive assessment of nonalcoholic fatty liver disease, including diagnosis, prognosis, and monitoring of NASH progression and treatment efficacy.

Explore computational biomedicine, focusing on epigenetics, liquid biopsy, and alternative polyadenylation therapy. Gain insights into cutting-edge research and applications in genomics and cancer detection.

Explore cutting-edge genomic technologies for liquid biopsy in cancer research, focusing on minimally invasive approaches to analyze biomarkers in blood samples.

Explore a novel integrated workflow for efficient CTC enrichment, enumeration, and identification in metastasis research. Learn about unbiased size selection and compatibility with various molecular and cellular applications.

Explore genomic and epigenomic analysis of cell-free DNA to predict survival in metastatic castration-resistant prostate cancer patients undergoing AR-directed therapy.

Explore personalized sequencing techniques for cerebrospinal fluid biopsies in pediatric brain tumor cases, enhancing diagnostic and monitoring capabilities.

Explore personalized ctDNA micro-panels for monitoring and predicting clinical outcomes in triple-negative breast cancer patients. Gain insights into advanced genomic testing techniques.

Explore advancements in liquid biopsies for early cancer detection and monitoring through integrated analyses of cell-free DNA and matched white blood cells.

Explore liquid biopsy techniques for non-invasive tumor analysis. Learn about circulating tumor cell enumeration and molecular profiling for cancer diagnosis and monitoring.

Explore droplet microfluidics in PCR, focusing on Digital Droplet PCR technology, its advantages over traditional qPCR, and applications in various fields like NIPT, pathogen detection, and liquid biopsy.

Explore cutting-edge tools for liquid biopsy in cancer research, enhancing early detection and treatment effectiveness. Learn from expert Dr. Laure Jobert about innovative approaches to combat this global health challenge.

Explore ctDNA hybridization capture for minimal residual disease research in cancer, overcoming challenges and discovering new biomarkers.

Discover groundbreaking techniques in cancer detection through cell-free DNA sequencing, exploring how immunotherapy measurements can revolutionize cancer treatment and immune system monitoring.

Explore novel biomarker-based assays for personalized cancer treatment. Learn about EIC Accelerator Challenge, its objectives, and innovative approaches in cancer diagnostics and therapy.